Skip to main content
. 2022 Aug 29;13:966416. doi: 10.3389/fimmu.2022.966416

Table 6.

Demographic characteristics of the immunogenicity study subsample.

Full dose (n = 154) Half dose (n = 558)
Mean Age ± SD 39.2 ± 6.4 33.3 ± 8.5*
Female % 84 50*

SD, standard deviation; Full dose, ChAdOx1 Full dose group; Half dose, ChAdOx1 Half dose group. *p < 0.05.